89bio, Inc
Why Robinhood?
You can watch 89bio, Inc and buy or sell other stocks, ETFs, and their options commission-free!About ETNB
89bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. Its product pipeline includes pegozafermin, FGF21, NASH, and SHTG.
ETNB Key Statistics
Stock Snapshot
As of today, 89bio, Inc(ETNB) shares are valued at $14.84. The company's market cap stands at 2.2B, with a P/E ratio of -4.12.
On 2026-03-31, 89bio, Inc(ETNB) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 7.1M.
Over the past 52 weeks, 89bio, Inc(ETNB) stock has traded between a high of $15.06 and a low of $4.16.
Over the past 52 weeks, 89bio, Inc(ETNB) stock has traded between a high of $15.06 and a low of $4.16.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.